Ad is loading...
CVMAX
Price
$17.33
Change
-$0.10 (-0.57%)
Updated
Nov 15 closing price
FNWFX
Price
$80.36
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

CVMAX vs FNWFX

Header iconCVMAX vs FNWFX Comparison
Open Charts CVMAX vs FNWFXBanner chart's image
Calvert Emerging Markets Equity A
Price$17.33
Change-$0.10 (-0.57%)
VolumeN/A
CapitalizationN/A
American Funds New World F3
Price$80.36
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
CVMAX vs FNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CVMAX vs. FNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVMAX is a Buy and FNWFX is a Buy.

FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 60.9B vs. CVMAX (1.37B). FNWFX pays higher dividends than CVMAX: FNWFX (1.56) vs CVMAX (0.70). CVMAX was incepted earlier than FNWFX: CVMAX (12 years) vs FNWFX (8 years). CVMAX is a more actively managed with annual turnover of: 59.00 vs. FNWFX (32.00). CVMAX has a lower initial minimum investment than FNWFX: CVMAX (1000) vs FNWFX (1000000). FNWFX annual gain was more profitable for investors over the last year : 11.59 vs. CVMAX (10.64). FNWFX return over 5 years is better than : 17.23 vs. CVMAX (5.38).
CVMAXFNWFXCVMAX / FNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years8 years-
Gain YTD7.1747.147100%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.37B60.9B2%
Annual Yield % from dividends0.701.5645%
Returns for 1 year10.6411.5992%
Returns for 3 years-18.11-14.49125%
Returns for 5 years5.3817.2331%
Returns for 10 years37.26N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EDU55.900.85
+1.54%
New Oriental Education and Technology Group
HTGC18.92-0.13
-0.68%
Hercules Capital
AZ6.49-0.11
-1.67%
A2Z Cust2Mate Solutions Corp
REPL10.80-0.60
-5.26%
Replimune Group
POAI0.69-0.05
-7.23%
Predictive Oncology